ProMIS Neurosciences Inc. - Common Shares, No Par Value (PMN)
CUSIP: 74346M406
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Shares, No Par Value
- Shares outstanding
- 9,081,600
- Total 13F shares
- 10,087,669
- Share change
- +6,438,188
- Total reported value
- $12,611,608
- Price per share
- $1.25
- Number of holders
- 18
- Value change
- +$8,040,363
- Number of buys
- 9
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 74346M406?
CUSIP 74346M406 identifies PMN - ProMIS Neurosciences Inc. - Common Shares, No Par Value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74346M406:
Top shareholders of PMN - ProMIS Neurosciences Inc. - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
20%
|
1,814,213
|
$2,721,320 | — | 30 Jun 2024 | |
| Ally Bridge Group (NY) LLC |
13F
|
Company |
12%
|
1,059,582
|
$1,589,373 | — | 30 Jun 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
2.9%
|
265,958
|
$398,937 | — | 30 Jun 2024 | |
| Gail M. Farfel |
3/4/5
|
Chief Executive Officer, Director |
—
mixed-class rows
|
108,384
mixed-class rows
|
$256,091 | — | 23 Aug 2023 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.33%
|
30,366
|
$55,266 | — | 30 Jun 2024 | |
| Hara Capital LLC |
13F
|
Company |
0.32%
|
29,416
|
$44,124 | — | 30 Jun 2024 | |
| IEQ CAPITAL, LLC |
13F
|
Company |
0.29%
|
26,042
|
$39,063 | — | 30 Jun 2024 | |
| FIDUCIARY TRUST CO |
13F
|
Company |
0.22%
|
20,008
|
$30,012 | — | 30 Jun 2024 | |
| Claret Asset Management Corp |
13F
|
Company |
0.12%
|
10,830
|
$16,000 | — | 30 Jun 2024 | |
| Gavin T. Malenfant |
3/4/5
|
Chief Operating Officer, Director |
—
mixed-class rows
|
17,820
mixed-class rows
|
$12,342 | — | 26 Oct 2023 | |
| Sandy Spring Bank |
13F
|
Company |
0.04%
|
3,300
|
$4,950 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
1,666
|
$2,499 | — | 30 Jun 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
713
|
$1,000 | — | 30 Jun 2024 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
333
|
$501 | — | 30 Jun 2024 | |
| TD Waterhouse Canada Inc. |
13F
|
Company |
0%
|
133
|
$202 | — | 30 Jun 2024 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
20
|
$30 | — | 30 Jun 2024 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
4
|
$6 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
3
|
$5 | — | 30 Jun 2024 | |
| Daniel E. Geffken |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
2,500
|
— | — | 26 Oct 2023 |
Institutional Holders of ProMIS Neurosciences Inc. - Common Shares, No Par Value (PMN) as of Q3 2024
As of 30 Sep 2024,
ProMIS Neurosciences Inc. - Common Shares, No Par Value (PMN) was held by
18 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,087,669 shares.
The largest 10 holders included
GREAT POINT PARTNERS LLC, ARMISTICE CAPITAL, LLC, SPHERA FUNDS MANAGEMENT LTD., Ally Bridge Group (NY) LLC, Altium Capital Management LP, HEIGHTS CAPITAL MANAGEMENT, INC, Affinity Asset Advisors, LLC, BANK OF MONTREAL /CAN/, IEQ CAPITAL, LLC, and Fiduciary Trust Co.
This page lists
18
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
15
Q3 2024 holders
18
Holder diff
3
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.